Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
Harinck F, Kluijt I, van der Stoep N, Oldenburg RA, Wagner A, Aalfs CM, Sijmons RH, Poley JW, Kuipers EJ, Fockens P, van Os TA, Bruno MJ.
Harinck F, et al. Among authors: poley jw.
J Med Genet. 2012 Jun;49(6):362-5. doi: 10.1136/jmedgenet-2011-100563. Epub 2012 May 25.
J Med Genet. 2012.
PMID: 22636603